Home Newsfeeds JP Morgan Assumes Bilibili at Overweight

JP Morgan Assumes Bilibili at Overweight

JP Morgan analyst Daniel Chen assumes Bilibili (NASDAQ:BILI) with a Overweight rating.

byBenzinga Newsdesk

September 7, 2022

1 minute read

JP Morgan analyst Daniel Chen assumes Bilibili (NASDAQ:BILI) with a Overweight rating.

M&A
News

Valens Shareholders Vote In Favour Of Arrangement With SNDL

By Michael Horton

November 29, 6:03 PM

The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") is pleased to announce that its shareholders have voted in favour

SNDL

Citigroup Initiates Coverage On Grupo Televisa with Buy Rating, Announces Price Target of $8.5

By Benzinga Newsdesk

February 14, 7:09 AM

Citigroup analyst Andres Cardona initiates coverage on Grupo Televisa (NYSE:TV) with a Buy rating and announces Price Target of $8.5.

Eli Lilly Says Lebrikizumab Monthly Maintenance Dosing At Two Years Demonstrated Efficacy For Patients With Eczema

By Shivani Kumaresan

October 20, 11:07 AM

Eli Lilly And Company (NYSE: LLY) said patients with moderate-to-seve

LLY

VectivBio Holding, Greenhill, Atea Pharmaceuticals And Other Big Stocks Moving Higher On Monday

By Lisa Levin

May 22, 10:31 AM

U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Friday. Here are some big stocks recording gains in today’s session. Greenhill & Co., Inc. (NYSE: GHL) shares rose 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

AVIR

JP Morgan Assumes Bilibili at Overweight

Related Posts

Valens Shareholders Vote In Favour Of Arrangement With SNDL

Citigroup Initiates Coverage On Grupo Televisa with Buy Rating, Announces Price Target of $8.5

Eli Lilly Says Lebrikizumab Monthly Maintenance Dosing At Two Years Demonstrated Efficacy For Patients With Eczema

VectivBio Holding, Greenhill, Atea Pharmaceuticals And Other Big Stocks Moving Higher On Monday